Alphabet's AI drug discovery company Isomorphic Labs is in talks to raise about $5bn in new funding at a valuation of about $50bn, people familiar with the matter told Bloomberg. The round is not finalised and details may change.
Isomorphic Labs in talks to raise about $5bn at a reported $50bn valuation
NewsFeeds update
More AI updates
Every update is a short rewrite, by AI in our own words, of a flash from the outlet named on it, credited and linked. Not investment advice.
Breaking news and our own Originals on your phone or desktop, the moment they are out. A few alerts a day at most.